News Abbott survey finds digital divide for patients, physicians Abbott's third report highlights disparities in digital health tool perceptions linger still.
Oncology Need for non-melanoma skin cancer guideline never greater Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, more than breast, bowel, and prostate cancer combined.
Digital 2023 predictions and challenges in the healthcare business With a new year comes an opportunity for professionals in the healthcare industry to evaluate goals and initiatives for 2023.
Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.
Views & Analysis Capturing progress in haemophilia care If we look back just 70 years, the prognosis for patients with haemophilia was remarkably different to what it is today.
Patients Time for change: PhRMA survey shows insurance creates barrie... Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
